Navigation Links
New nanotech products hitting the market at the rate of 3-4 per week
Date:4/24/2008

roducts are zinc (including zinc oxide) and titanium (including titanium dioxide), silica and gold.

While polls show most Americans know little or nothing about nanotechnology, in 2006 nanotechnology was incorporated into more than $50 billion in manufactured goods. By 2014, Lux Research estimates $2.6 trillion in manufactured goods will incorporate nanotechnologyor about 15 percent of total global output. Despite a 2006 worldwide investment of $12.4 billion in nanotech R&D, comparatively little was spent on examining nanotechnologys potential environmental, health and safety risks.

Public trust is the dark horse in nanotechnologys future, says Rejeski in his testimony. If government and industry do not work to build public confidence in nanotechnology, consumers may reach for the No-Nano label in the future and investors will put their money elsewhere.

According to Rejeski, The use of nanotechnology in consumer products and industrial applications is growing rapidly, with the products listed in the PEN inventory showing just the tip of the iceberg. Public perceptions about risksreal and perceivedcan have large economic consequences. How consumers respond to these early productsin food, electronics, health care, clothing and carsis a litmus test for broader market acceptance of nanotechnologies in the future.


'/>"/>

Contact: Alex Parlini
alex.parlini@wilsoncenter.org
301-768-8366
Project on Emerging Nanotechnologies
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Improved Governance Needed To Realize Nanotechs Benefits
2. Hill-Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill-Rom Products Using Nanotechnology
3. Breakthroughs in nanotechnology on edge of knowledge frontier
4. Federal toxics disclosure law could help inform public of nanotechnology risks
5. Cleaner water through nanotechnology
6. Nanotechnologys future depends on who the public trusts
7. Nanotech Briefs Announces Call for Nominations for the Fourth Annual Nano 50(TM) Awards
8. EPA takes first step in filling nanotech information gaps
9. NIST reference materials are gold standard for bio-nanotech research
10. UCLA-industry partnership to develop, commercialize new nanotechnology
11. Food and Drug Law Institute, Project on Emerging Nanotechnologies Co-Sponsor Major Conference on Nanotechnology Law, Regulation and Policy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New nanotech products hitting the market at the rate of 3-4 per week
New nanotech products hitting the market at the rate of 3-4 per week
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...A new immunosuppression regimen for heart transpla...t transplant coronary artery disease//, according ...ill report their findings on April 26 at The Inter...splantation Annual Meeting and Scientific Session ...
...An international research team, led by investigato...ancer Center and Dana-Farber Cancer Institute (DFC...come resistant to treatment with targeted therapy ...ch will appear in the journal Science and is recei...
...Results of a Japanese study have given drug gian... the study published in The Lancet, the company’s ...e the risks of strokes and cardiovascular events b...e Jikei Heart Study, was based on 3,000 people age...
...A simple scoring system based on five medical fact...dered for gastric bypass surgery would be at highe... first proposed last year by Duke University Medic... in a new study of more than 4,400 patients. The s...
Other Medicine News:Health News:Mayo Clinic Study Finds Heart Transplant Patients Benefit from New Approach to Immunosuppression 2Health News:New Mechanism Identified for Resistance to Targeted Lung Cancer Drugs 2Health News:New Mechanism Identified for Resistance to Targeted Lung Cancer Drugs 3Health News:Novartis Drug Diovan Shows Superior Benefits 2Health News:Simple System Accurately Predicts Weight-loss Surgery Risk 2Health News:Simple System Accurately Predicts Weight-loss Surgery Risk 3
(Date:10/7/2008)...Stage A of Trial Assessing Regimen of Bavituxim...-, TUSTIN, Calif., Oct. 7 /PRNewswire-FirstCall/ ...), a clinical stage biopharmaceutical,company deve...cancer and,hepatitis C virus (HCV) infection, toda...e first stage of a Phase II trial of bavituximab i...
(Date:10/6/2008)...irstCall/ -- Pharmasset, Inc.,(Nasdaq: VRUS ) ann...the,Company as Vice President of Investor Relation...responsible for all investor relations,functions a... Kurt,Leutzinger., Most recently, Dr. Smith was a...t JPMorgan Securities, and has been an analyst in ...
(Date:10/6/2008)... Scientific Conference -, ORLANDO, Fla., Oct. 6 /...Microbia) today announced presentation of data fro...le that cyclic guanosine,monophosphate (cGMP) play...monstrate that cGMP inhibits intestinal pain in a ...esensitizes colonic afferent nerves in a,similar m...
(Date:10/6/2008)...urezol Dosed Prior to Surgery, TAMPA, Fla., Oct. ...vately held ophthalmic-focused biopharmaceutical c...dnate ophthalmic emulsion) 0.05% is now,commercial....S. Food and,Drug Administration in June 2008, is ...the treatment of inflammation and pain associated ...
Breaking Medicine Technology:Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5New leukemia signal could point way to better treatment Stanford researchers find 26527 1New leukemia signal could point way to better treatment Stanford researchers find 26527 2 Caterpillar Logistics Services Retirees Win a Preliminary Injunction Providing Them Premium Free Retiree Healthcare 26525 1 Caterpillar Logistics Services Retirees Win a Preliminary Injunction Providing Them Premium Free Retiree Healthcare 26525 2 Caterpillar Logistics Services Retirees Win a Preliminary Injunction Providing Them Premium Free Retiree Healthcare 26525 3NJHA 3A Hospitals Achieve Gains in Healthcare Quality But Commitment to Improve Continues 26522 1NJHA 3A Hospitals Achieve Gains in Healthcare Quality But Commitment to Improve Continues 26522 2Message to North Carolina Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 26519 1Message to North Carolina Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 26519 2Message to North Carolina Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 26519 3
...d,today announced results from a study published i...that suggest infusions of a novel,new drug, CSL-11...terol) levels, may reduce the amount of plaque in ...isode of acute,coronary syndrome (ACS). , CSL advi...sclerosis – Safety and Efficacy (ERASE) tria...
...Interleukin,Genetics, Inc. (AMEX:ILI) and collabor...day reported at the American College of,Cardiology... artery,disease (CAD) and both oxidized phospholip... on pro-inflammatory variants of the,interleukin-1...uence of Oxidized,Phospholipids and Lp(a) Lipoprot...
Other Medicine Technology:CSL Therapy That Mimics “Good” Cholesterol May Reduce,Plaque Volume in Coronary Arteries 2CSL Therapy That Mimics “Good” Cholesterol May Reduce,Plaque Volume in Coronary Arteries 3ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 2ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 3
Basic-level interpretive resting ECG
Mid-level interpretive resting ECG
Cruise Control is a device developed by STAAR as a filter between the phaco handpiece and aspiration tubing that captures nuclear material, enhances the safety and efficiency of phaco procedures by e
...rovides the ultimate flexibility for performing sl... a patient room or in the sleep laboratory. Travel...an VISION analysis software as your in-lab studies...f many powerful Sleepscan features such as the VIS...
Medicine Products: